The total return over the past 12 months is +43.65% vs. +22.54% for the S&P 500. So far it's up +23.02% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +42.79% | (4.57%) | (9.06%) | +10.02% | +10.01% | +9.47% |
| Total Return CAGR | +43.65% | (4.08%) | (8.65%) | +10.69% | +10.98% | +10.46% |
| Revenue CAGR | +0.17% | +2.52% | +7.39% | +9.65% | +10.29% | +9.47% |
| Net Income CAGR | (16.78%) | (26.08%) | (9.88%) | +0.41% | (0.02%) | +2.09% |
| EPS CAGR | (14.46%) | (35.23%) | (20.72%) | (4.31%) | (2.98%) | +0.69% |
| Free Cash Flow CAGR | +22.13% | +5.02% | +3.72% | +8.09% | +5.50% | +6.90% |
| Operating Cash Flow CAGR | +11.33% | +2.51% | +1.41% | +7.38% | +5.93% | +7.08% |
| Dividends CAGR | 0.00% | 0.00% | 0.00% | 0.00% | +1.33% | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bio-Techne Corporation (TECH)
| Year | Start price | End price | TECH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $58.81 | $72.12 | +23.02% | +13.96% | +9.06% |
| 2025 | $72.03 | $58.81 | (17.89%) | +17.72% | (35.61%) |
| 2024 | $77.16 | $72.03 | (6.25%) | +24.89% | (31.14%) |
| 2023 | $82.88 | $77.16 | (6.49%) | +26.19% | (32.68%) |
| 2022 | $129.34 | $82.88 | (35.70%) | (18.17%) | (17.53%) |
| 2021 | $79.39 | $129.34 | +63.39% | +28.74% | +34.65% |
| 2020 | $54.88 | $79.39 | +45.39% | +18.37% | +27.02% |
| 2019 | $36.18 | $54.88 | +52.68% | +31.22% | +21.46% |
| 2018 | $32.39 | $36.18 | +12.60% | (4.56%) | +17.16% |
| 2017 | $25.71 | $32.39 | +27.40% | +21.70% | +5.70% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
